I don't care about your posts mate. But this is what they said...

I don't care about your posts mate. But this is what they said in the Ann today and it isn't good enough for you! That's your problem! And I hope you stick to your word as you've said to others in other stocks?
"Commercially it is expected that the partnership would result in a seven-figure royalty for the initial
12 months of sales commencing FY2021 on launch of the first Mobvoi wearable device “powered by
ATCOR”. This assumes a single device integration at launch. Assuming both growth in unit sales of the
smart-watch as well as the expansion of “powered by ATCOR” into other lines of smart-watches and
other wearable devices, such as smart earbuds, a conservative annual growth rate of 20-30% for the
following four years is reasonable for royalty payments.
A successful commercial launch with Mobvoi also enables CardieX to replicate the same type of
technology partnership model with other OEMs of PPG-based consumer wearables. A reasonable
assumption would be one to two technology partnerships per year, resulting in incremental revenue
streams from royalty payments starting between 12 to 24 months after technology partnership is
launched. Magnitude of royalty payments depends on ASP (average selling price) of the wearable
device, but expectation is between 3-5% of ASP based on current commercial discussions.
Secondary revenue streams will derive from subscription services that are powered by the ATCOR
smart-watch and smart-phone apps. The commercial approach is a freemium model whereby basic
versions of both apps with basic smart heart health ecosystem features are easily accessible and free
to download. However, a monthly subscription fee will apply on a per-user level to unlock premium
features that deliver a richer and more engaging user experience created on the foundation of
relevant and actionable insights on the user’s cardiovascular health.
Similar to the technology partnership characterized above, this app-based ecosystem is also replicable
in the form of a white-label heart health platform for enterprise customers, such as health insurers
and large employers. Therefore, accessible to individual consumers via app stores, the heart health
ecosystem can also be deployed on a wider scale.
Overall, the combination of royalty fee per unit of sales and recurring subscription fee creates a
sustainable and scalable razor-razor blade model that leverages our core technology and enables
collection of user physiological data. The key is producing a creatively engaging user experience for a
target audience with very short attention span and converting each new user into a “stubbornly” sticky
customer.
All of the above add up to a significant and material financial and strategic opportunity for the Cardiex
Group.
Finally, it’s worth repeating the significance of this transaction for us as a company and for our
shareholders. We now have a future revenue generating partnership and are part of the Google
network via the largest platform for Google’s Wear OS platform in the biggest market in the world. "
Now just boot off mate.